Should Patients Receiving ACE Inhibitors or Angiotensin Receptor Blockers be Switched to Other Antihypertensive Drugs to Prevent or Improve Prognosis of Novel Coronavirus Disease 2019 (COVID-19)?

Racagni G.;Bernardini R.;Pistis M.;Taglialatela M.
2020-01-01
2020
2020
Inglese
DRUG SAFETY
43
6
507
509
3
WOS:000533786900001
2-s2.0-85083646580
32303915
https/link.springer.com/content/pdf/10.1007/s40264-020-00935-2.pdf
Esperti anonimi
internazionale
scientifica
no
Trifiro, G.; Crisafulli, S.; Ando, G.; Racagni, G.; Drago, F.; Berrino, L.; Re, M.; Bernardini, R.; Chiamulera, C.; D'Avolio, A.; Pani, L.; Clementi, ...espandi
1.1 Articolo in rivista
info:eu-repo/semantics/article
1 Contributo su Rivista::1.1 Articolo in rivista
262
24
open
Files in This Item:
File Size Format  
Trifiro-2020-Should-patients-receiving-ace-inhib.pdf

open access

Description: articolo principale
Type: versione editoriale
Size 538.72 kB
Format Adobe PDF
View/Open
538.72 kB Adobe PDF View/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Questionnaire and social

Share on:
Impostazioni cookie